Due to the coronavirus pandemic, we will be holding our advisory committee meetings virtually until further notice. Some meetings may be rescheduled or cancelled if we need to reprioritise our work.

These meetings are open to the public and press to observe. Holding them in public supports our commitment to having processes in place that are rigorous, open, and transparent. You can find planned meeting dates under 'About the committee' and register to observe meetings under 'Scheduled meetings'.

For more information, read the common questions and answers about virtual committee meetings (Word).

 

Antimicrobials evaluation committee (AMEC)

The antimicrobials evaluation committee has been convened to test a new health technology evaluation process on 2 antimicrobial drugs. The independent committee will consider the evidence and make a judgement on the value of the drugs to the NHS.

About the antimicrobial evaluation committee

About the antimicrobials project

  • No scheduled meetings found

  • No previous meetings found

Diagnostics advisory committee (DAC)

The diagnostics advisory committee advises NICE about the formulation of guidance on diagnostics technologies and any other matter related to the evaluation of diagnostic technologies, as requested.

About the diagnostics advisory committee

About diagnostics guidance

  • Diagnostic Advisory Committee (DAC) meeting
  • 25 May 2022
  • via Zoom
  • View details

  • Diagnostic Advisory Committee (DAC) meeting
  • 26 April 2022
  • via Zoom
  • View details

Highly specialised technologies evaluation committee (HSTEC)

The highly specialised technologies evaluation committee is an independent standing committee that produces recommendations on when and how a highly specialised technology should be commissioned for use in the NHS in England.

About the highly specialised technologies evaluation committee

About highly specialised technologies guidance

  • Highly specialised technologies evaluation committee
  • 08 June 2022
  • via Zoom
  • View details

  • Highly specialised technologies evaluation committee
  • 13 April 2022
  • via Zoom
  • View details

Indicator advisory committee (IAC)

The indicator advisory committee develops indicators that are suitable for potential inclusion in the Quality and Outcomes Framework (QOF) and the Clinical Commissioning Group Outcome Indicator Set (CCG OIS). NICE indicators can also be used by other stakeholders for other national or local quality improvement initiatives.

About the indicator advisory committee

  • No scheduled meetings found

  • No previous meetings found

Interventional procedures advisory committee (IPAC)

The interventional procedures advisory committee makes recommendations about the efficacy and safety of interventional procedures and the context of guidance, such as conditions under which procedures should be used.

About the interventional procedures advisory committee

About interventional procedures guidance

  • Interventional procedures advisory committee (IPAC) meeting
  • 09 June 2022
  • via Zoom
  • View details

  • Interventional procedures advisory committee (IPAC) meeting
  • 12 May 2022
  • via Zoom
  • View details
  • Interventional procedures advisory committee (IPAC) meeting
  • 14 April 2022
  • via Zoom
  • View details

Medical technologies advisory committee (MTAC)

The medical technologies advisory committee supports the Medical Technologies Evaluation Programme. They identify and select innovative medical technologies and route these products to the appropriate guidance production programme. The committee also develops recommendations to be issued as medical technologies guidance.

About the medical technologies advisory committee

About medical technologies guidance

  • No scheduled meetings found

  • Medical technologies advisory committee meeting
  • 20 May 2022
  • via Zoom
  • View details
  • Medical technologies advisory committee meeting
  • 22 April 2022
  • via Zoom
  • View details

Public health advisory committee (PHAC)

Public health advisory committees are the standing committees responsible for the development of our public health guidance. 

Guidance topics are allocated to a committee following referral from the Department of Health. The committee considers the evidence and makes recommendations for people working in the NHS, local government and in the wider public, private and voluntary sectors.

About the public health advisory committee

About public health guidelines

  • No scheduled meetings found

  • No previous meetings found

Quality standards advisory committee (QSAC)

The quality standards advisory committees are independent committees that help to develop our quality standards. They are made up of standing members and specialist members from the key source guidance development group for each quality standard topic being considered.

About the quality standards advisory committee

About quality standards

  • Quality standards advisory committee 3 (QSAC 3) meeting
  • 25 May 2022
  • via Zoom
  • View details

  • Quality standards advisory committee 2 (QSAC 2) meeting
  • 17 May 2022
  • via Zoom
  • View details
  • Quality standards advisory committee 3 (QSAC 3) meeting
  • 27 April 2022
  • via Zoom
  • View details

Technology appraisal committee (TAC)

The technology appraisal committee is an independent standing committee that produces recommendations. They consider the evidence and make a judgement on whether or not the technology should be recommended as a clinically and cost-effective use of NHS resources, or whether it should only be recommended for specific indications or subgroups of patients.

About the technology appraisal committee

About technology appraisal guidance

  • Technology appraisal committee meeting (Committee D)
  • 26 May 2022
  • via Zoom
  • View details
  • Technology appraisal committee meeting (Committee C)
  • 01 June 2022
  • via Zoom
  • View details
  • Technology appraisal committee meeting (Committee A)
  • 07 June 2022
  • via Zoom
  • View details
  • Technology appraisal committee meeting (Committee B)
  • 09 June 2022
  • via Zoom
  • View details

  • Technology appraisal committee meeting (Committee B)
  • 12 May 2022
  • via Zoom
  • View details
  • Technology appraisal committee meeting (Committee A)
  • 10 May 2022
  • via Zoom
  • View details
  • Technology appraisal committee meeting (Committee D)
  • 05 May 2022
  • via Zoom
  • View details
  • Technology appraisal committee meeting (Committee C)
  • 04 May 2022
  • via Zoom
  • View details
  • Technology appraisal committee meeting (Committee B)
  • 14 April 2022
  • via Zoom
  • View details
  • Technology appraisal committee meeting (Committee A)
  • 12 April 2022
  • via Zoom
  • View details
  • Technology appraisal committee meeting (Committee D)
  • 07 April 2022
  • via Zoom
  • View details
  • Technology appraisal committee meeting (Committee C)
  • 06 April 2022
  • via Zoom
  • View details

Our formal board meetings are open to the public to observe and ask questions, unless there are confidential matters to discuss.

Due to the coronavirus pandemic, our public board meetings are currently being held virtually.

About the board

Read the papers from previous board meetings

Public board meetings

  • NICE Public Board meeting
  • 25 May 2022
  • via Zoom
  • View details
  • NICE Public Board meeting
  • 22 July 2022
  • via Zoom
  • View details
  • NICE Public Board meeting
  • 22 September 2022
  • via Zoom
  • View details
  • NICE Public Board meeting
  • 23 November 2022
  • via Zoom
  • View details

  • NICE Public Board meeting
  • 17 March 2022
  • via Zoom
  • View details

Due to the coronavirus pandemic, we will be holding our technology appraisal appeal hearings virtually until further notice. Some meetings may be rescheduled or cancelled if we need to reprioritise our work.

Stakeholders, members of the public and press are welcome to observe oral appeals. Holding them in public supports our commitment to having processes in place that are rigorous, open, and transparent. This enables everyone to better understand the way we make our decisions.

Find out more about appeals.

 

Technology appraisal appeals

  • No scheduled meetings found

  • Appeal: Fostamatinib for treating refractory chronic immune thrombocytopenia [ID1087]
  • 09 November 2021
  • via Zoom
  • View details